The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / More Than Skin Deep: Insights into Clinical Challenges in Psoriatic Arthritis

More Than Skin Deep: Insights into Clinical Challenges in Psoriatic Arthritis

October 7, 2019 • By Jason Liebowitz, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

MADRID—In recent years, the features that make psoriatic arthritis (PsA) distinct from rheumatoid arthritis (RA) have gained increasing attention and allowed for a better understanding of the disease. Recently, a review article in RMD Open described how PsA includes asymmetric joint involvement, may involve the axial spine and may be seronegative for rheumatoid factor (RF) and cyclic citrullinated peptide (CCP). All of these features are not as common in RA. Moreover, differences in the pathogenesis of PsA and RA explain why the specificity and efficacy of certain therapies vary between the two diseases.1

You Might Also Like
  • Apremilast Effective for Psoriatic Arthritis
  • Study Shows Psoriatic Arthritis Impacts Women More Than Men
  • A Rash of Evidence: Evaluating & Treating Psoriatic Arthritis
Explore This Issue
October 2019
Also By This Author
  • Malignant Complications: Screening for Cancer in Rheumatic Diseases

Although understanding the differences between PsA and other forms of inflammatory arthritis is important, so too is recognizing the variations in PsA phenotypes in patients, as well as how these individual subpopulations should be treated.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

At the 2019 European Congress of Rheumatology (EULAR), June 12–15, during a session titled, The Multiple Rheumatological Faces of Psoriatic Arthritis, Laura Coates, MBChB, MRCP, PhD, a clinician scientist and senior clinical research fellow at the National Institute for Health Research at the University of Oxford, England, described the five classic subtypes of patients with PsA. As noted in prior research from 1973, these patient subtypes are:

  1. Patients with classic PsA, with distal interphalangeal joint involvement;
  2. Patients with arthritis mutilans;
  3. Seronegative patients with symmetric patterns of joint involvement similar to RA;
  4. Patients with predominant axial spine involvement; and
  5. Patients with single or few finger or toe joints involved, typically with scattered distal interphalangeal joint, proximal interphalangeal joint and metatarsophalangeal joint involvement.2

It’s this last group that includes patients with monoarthritis or oligoarthritis, a cohort traditionally regarded as distinct from patients with polyarthritis (i.e., individuals with five or more joints involved by PsA). Dr. Coates noted that even the simple step of classifying patients is not always straightforward. A study evaluated 500 patients with oligoarticular PsA with a 28-joint count and then re-evaluated them with a 68-tender and 66-swollen joint count. The 28-joint count missed 21% of patients with tender joints and 27% of patients with swollen joints. This study implies that a full 66/68 joint count is important for assessing disease activity in PsA patients and properly classifying patients as oligoarticular or polyarticular.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In comparing monoarticular/oligoarticular and polyarticular PsA patients, Dr. Coates pointed to work from the U.K. This research showed that although the groups differed by age, sex, disability score and symmetry, no differences existed between them in terms of seropositivity for RF and CCP, enthesitis, or spinal pain and stiffness. And aside from entheseal changes, syndesmophytes and osteolysis, typical radiological features of PsA could not be used to distinguish between the groups.4

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: EULAR, PsA Resource Center, Psoriatic Arthritis, skinIssue: October 2019

You Might Also Like:
  • Apremilast Effective for Psoriatic Arthritis
  • Study Shows Psoriatic Arthritis Impacts Women More Than Men
  • A Rash of Evidence: Evaluating & Treating Psoriatic Arthritis
  • Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.